proline has been researched along with Hemophilia A in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Kakizaki, S; Kanayama, Y; Ohnishi, H; Okamoto, H; Sato, K; Suga, T; Tojima, H; Uehara, D; Uraoka, T; Yamazaki, Y; Yanagisawa, K | 1 |
| Bayry, J; Christophe, O; Dasgupta, S; Delignat, S; Friboulet, A; Hoebeke, J; Kaveri, SV; Kazatchkine, MD; Lacroix-Desmazes, S; Nagaraja, V; Reinbolt, J; Saenko, E; Wootla, B | 1 |
| Bajaj, SP; Birktoft, JJ; Kasper, CK; Kuppuswamy, MN; Saini, R; Spitzer, SG | 1 |
3 other study(ies) available for proline and Hemophilia A
| Article | Year |
|---|---|
Successful treatment of Japanese hemophilia patient co-infected with HIV and HCV genotype 4a by glecaprevir/pibrentasvir therapy.
Topics: Aminoisobutyric Acids; Antiviral Agents; Benzimidazoles; Coinfection; Cyclopropanes; Genotype; Hemophilia A; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Japan; Lactams, Macrocyclic; Leucine; Proline; Pyrrolidines; Quinoxalines; Sulfonamides | 2021 |
Catalytic IgG from patients with hemophilia A inactivate therapeutic factor VIII.
Topics: Adolescent; Adult; Aged; Antibodies, Catalytic; Arginine; Binding Sites, Antibody; Blood Coagulation; Child; Coumarins; Factor VIII; Hemophilia A; Humans; Hydrolysis; Immunoglobulin G; Middle Aged; Oligopeptides; Phenylalanine; Proline | 2006 |
Factor IXHollywood: substitution of Pro55 by Ala in the first epidermal growth factor-like domain.
Topics: Alanine; Amino Acid Sequence; Base Sequence; Deoxyribonucleases, Type II Site-Specific; DNA; DNA Restriction Enzymes; Epidermal Growth Factor; Exons; Factor IX; Factor IXa; Genetic Markers; Hemophilia A; Humans; Molecular Sequence Data; Mutation; Partial Thromboplastin Time; Polymerase Chain Reaction; Proline; Promoter Regions, Genetic; Protein Conformation | 1990 |